127 related articles for article (PubMed ID: 19807742)
21. Mild phenotype of familial cylindromatosis associated with an R758X nonsense mutation in the CYLD tumour suppressor gene.
Oiso N; Mizuno N; Fukai K; Nakagawa K; Ishii M
Br J Dermatol; 2004 Nov; 151(5):1084-6. PubMed ID: 15541090
[TBL] [Abstract][Full Text] [Related]
22. Brooke-Spiegler syndrome: report of two cases not associated with a mutation in the CYLD and PTCH tumor-suppressor genes.
Ponti G; Nasti S; Losi L; Pastorino L; Pollio A; Benassi L; Giudice S; Bertazzoni G; Veratti E; Azzoni P; Bianchi Scarrà G; Seidenari S
J Cutan Pathol; 2012 Mar; 39(3):366-71. PubMed ID: 22077640
[TBL] [Abstract][Full Text] [Related]
23. [Brooke-Spiegler syndrome: an heterogeneous entity].
Mataix J; Bañuls J; Botella R; Laredo C; Lucas A
Actas Dermosifiliogr; 2006 Dec; 97(10):669-72. PubMed ID: 17173833
[TBL] [Abstract][Full Text] [Related]
24. Cylindroma as tumor of hair follicle origin.
Massoumi R; Podda M; Fässler R; Paus R
J Invest Dermatol; 2006 May; 126(5):1182-4. PubMed ID: 16484982
[No Abstract] [Full Text] [Related]
25. Brooke-Spiegler syndrome: report of a case of multiple cylindromas and trichoepitheliomas.
Doherty SD; Barrett TL; Joseph AK
Dermatol Online J; 2008 Jul; 14(7):8. PubMed ID: 18718192
[TBL] [Abstract][Full Text] [Related]
26. Targeting Tropomyosin Receptor Kinase in Cutaneous CYLD Defective Tumors With Pegcantratinib: The TRAC Randomized Clinical Trial.
Danilenko M; Stamp E; Stocken DD; Husain A; Zangarini M; Cranston A; Stones R; Sinclair N; Hodgson K; Bowett SA; Roblin D; Traversa S; Plummer R; Veal G; Langtry JAA; Ashworth A; Burn J; Rajan N
JAMA Dermatol; 2018 Aug; 154(8):913-921. PubMed ID: 29955768
[TBL] [Abstract][Full Text] [Related]
27. Novel and recurrent germline and somatic mutations in a cohort of 67 patients from 48 families with Brooke-Spiegler syndrome including the phenotypic variant of multiple familial trichoepitheliomas and correlation with the histopathologic findings in 379 biopsy specimens.
Grossmann P; Vanecek T; Steiner P; Kacerovska D; Spagnolo DV; Cribier B; Rose C; Vazmitel M; Carlson JA; Emberger M; Martinek P; Pearce RL; Pearn J; Michal M; Kazakov DV
Am J Dermatopathol; 2013 Feb; 35(1):34-44. PubMed ID: 23249834
[TBL] [Abstract][Full Text] [Related]
28. A case of Brooke-Spiegler syndrome with a new mutation in the CYLD gene.
Heinritz W; Grunewald S; Strenge S; Schütz A; Froster UG; Glander HJ; Paasch U; Simon JC
Br J Dermatol; 2006 May; 154(5):992-4. PubMed ID: 16634909
[No Abstract] [Full Text] [Related]
29. Diverse phenotype of Brooke-Spiegler syndrome associated with a nonsense mutation in the CYLD tumor suppressor gene.
Zhang G; Huang Y; Yan K; Li W; Fan X; Liang Y; Sun L; Li H; Zhang S; Gao M; Du W; Yang S; Liu J; Zhang X
Exp Dermatol; 2006 Dec; 15(12):966-70. PubMed ID: 17083363
[TBL] [Abstract][Full Text] [Related]
30. Mutations in the CYLD gene in Brooke-Spiegler syndrome, familial cylindromatosis, and multiple familial trichoepithelioma: lack of genotype-phenotype correlation.
Bowen S; Gill M; Lee DA; Fisher G; Geronemus RG; Vazquez ME; Celebi JT
J Invest Dermatol; 2005 May; 124(5):919-20. PubMed ID: 15854031
[TBL] [Abstract][Full Text] [Related]
31. Cylindroma of the breast with CYLD gene mutation: a case report and review of the literature.
Escher-Michlig V; Vlajnic T; Roma L; Marinucci M; Piscuoglio S; Matter M; Haug M; Weber WP; Muenst S
Mol Biol Rep; 2023 Aug; 50(8):7133-7139. PubMed ID: 37389703
[TBL] [Abstract][Full Text] [Related]
32. Five new CYLD mutations in skin appendage tumors and evidence that aspartic acid 681 in CYLD is essential for deubiquitinase activity.
Almeida S; Maillard C; Itin P; Hohl D; Huber M
J Invest Dermatol; 2008 Mar; 128(3):587-93. PubMed ID: 17851586
[TBL] [Abstract][Full Text] [Related]
33. Inherited pulmonary cylindromas: extending the phenotype of CYLD mutation carriers.
Brown SM; Arefi M; Stones R; Loo PS; Barnard S; Bloxham C; Stefanos N; Langtry JAA; Worthy S; Calonje E; Husain A; Rajan N
Br J Dermatol; 2018 Sep; 179(3):662-668. PubMed ID: 29569226
[TBL] [Abstract][Full Text] [Related]
34. Germline mutation analysis in the CYLD gene in Chinese patients with multiple trichoepitheliomas.
Li ZL; Guan HH; Xiao XM; Hui Y; Jia WX; Yu RX; Chen H; Li CR
Genet Mol Res; 2014 Nov; 13(4):9650-5. PubMed ID: 25501176
[TBL] [Abstract][Full Text] [Related]
35. Loss of heterozygosity at cylindromatosis gene locus, CYLD, in sporadic skin adnexal tumours.
Leonard N; Chaggar R; Jones C; Takahashi M; Nikitopoulou A; Lakhani SR
J Clin Pathol; 2001 Sep; 54(9):689-92. PubMed ID: 11533075
[TBL] [Abstract][Full Text] [Related]
36. Loss of CYLD might be associated with development of salivary gland tumors.
Fukuda M; Hiroi M; Suzuki S; Ohmori Y; Sakashita H
Oncol Rep; 2008 Jun; 19(6):1421-7. PubMed ID: 18497946
[TBL] [Abstract][Full Text] [Related]
37. Milia: a useful clinical marker of CYLD mutation carrier status.
Bajwa DS; Nasr B; Carmichael AJ; Rajan N
Clin Exp Dermatol; 2018 Mar; 43(2):193-195. PubMed ID: 29023940
[No Abstract] [Full Text] [Related]
38. Clinical, genetic and experimental studies of the Brooke-Spiegler (CYLD) skin tumor syndrome.
Andersson MK; Kölby L; Nilsson JA; Stenman G
J Plast Surg Hand Surg; 2019 Apr; 53(2):71-75. PubMed ID: 30676842
[TBL] [Abstract][Full Text] [Related]
39. Large germline deletions of the CYLD gene in patients with Brooke-Spiegler syndrome and multiple familial trichoepithelioma.
Vanecek T; Halbhuber Z; Kacerovska D; Martinek P; Sedivcova M; Carr RA; Slouka D; Michal M; Kazakov DV
Am J Dermatopathol; 2014 Nov; 36(11):868-74. PubMed ID: 25347032
[TBL] [Abstract][Full Text] [Related]
40. Brooke-Spiegler syndrome: report of a case with a novel mutation in the CYLD gene and different types of somatic mutations in benign and malignant tumors.
Kazakov DV; Schaller J; Vanecek T; Kacerovska D; Michal M
J Cutan Pathol; 2010 Aug; 37(8):886-90. PubMed ID: 20132422
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
